Related Experiment Video
Updated: Jan 1, 2026

07:38
Generating Acute and Chronic Experimental Models of Motor Tic Expression in Rats
Published on: May 27, 2021
8.6K
Models of hyperkinetic disorders in primates
1Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France.
Journal of Neuroscience Methods
|December 21, 2019
Summary
Non-human primate models are crucial for studying hyperkinetic movement disorders like Parkinson's disease and Huntington's disease. This review examines their current use and future potential in research.
Area of Science:
- Neuroscience
- Movement Disorders Research
- Primate Models in Medicine
Background:
- Hyperkinetic movement disorders encompass a range of conditions characterized by abnormal involuntary movements.
- A limited subset of these disorders, including L-dopa-induced dyskinesia, tardive dyskinesia, essential tremor, and Huntington's disease, are modeled in non-human primates.
Purpose of the Study:
- To review the current utility of non-human primate models for hyperkinetic movement disorders.
- To discuss future directions and developments in the application of these models.
Main Methods:
- Literature review of existing non-human primate models for specific hyperkinetic movement disorders.
- Analysis of the current state and limitations of these models.
- Discussion of potential future advancements and applications.
Main Results:
- Non-human primate models are established for key hyperkinetic disorders such as Parkinson's disease with L-dopa-induced dyskinesia, tardive dyskinesia, essential tremor, and Huntington's disease.
- These models offer valuable insights into the pathophysiology and treatment of these complex neurological conditions.
Conclusions:
- Non-human primate models remain essential tools for advancing the understanding and treatment of debilitating hyperkinetic movement disorders.
- Further development and application of these models are critical for future therapeutic breakthroughs.

